The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Share News (ABC)

  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Broker tips: Ocado, Abcam

Tue, 20th Jun 2023 08:22

(Sharecast News) - Online supermarket Ocado was under the cosh on Tuesday after JPMorgan Cazenove cut its price target on the shares to 400p from 450p and placed the stock on 'negative catalyst watch' into first-half results.

JPM said: "We believe Ocado's online grocery activities will continue to face meaningful headwinds in the next months."

The bank, which rates Ocado at 'underweight', said the latest Kantar data suggest ongoing market share gains for offline discounters given the current macro backdrop/falling consumer budgets.

It also noted that higher, inflation-driven average selling prices are almost fully offset by lower basket sizes, while cost inflation - wages but also electricity, icing etc - is negatively impacting UK Retail's bottom line.

JPM said it sees downside to consensus FY23 estimates.

"With Ocado's UK Retail operations barely profitable in 2023, we see limited scope for Retail to act as the required showcase for the company's Solutions operation," it said.

It also said it's "becoming clearer" that the shift towards more customer fulfilment centres (CFCs) is likely to remain slow for supermarkets as in-store picking solutions seem currently to be the preferred choice to better monetise the established branch network and limit capex.

JPM said that despite Ocado's recent share price weakness - the shares are down 30% year-to-date and 44% in the last 12 months - the current share price levels still reflect an additional 54 CFCs to be announced.

"With (a lack of) new partnership announcements likely to remain the key share price driver from here, we see risk-reward still as unattractive versus other names in the EU Internet sector and remain UW."

RBC Capital Markets downgraded Abcam to 'sector perform' from 'outperform' and cut the price target to $22 from $23 as it recommended investors take profit on bid anticipation.

It noted that the shares are up 40% in the last 10 days, and 65% in the quarter to date.

"It is unclear how advanced the 'strategic inquiries' are, and the valuation work in this report implies relatively little further upside on a transaction anyway," RBC said.

"We have always liked Abcam's fundamentals but see activist investor engagement and anticipation of a potential bid as likely to drive material volatility in the shares.

"While our $22 price target informs our downgrade to sector perform, we would take profits here."

More News
11 Nov 2015 14:32

Abcam agrees AxioMx takeover

(ShareCast News) - Protein research tools producer Abcam has reached an agreement to acquire monoclonal antibodies producer AxioMx in a deal worth up to $45m (£29.7m). The London-listed company said it will pay $20m upfront for AxioMx, with a further $25m due based on the US-based company achieve ce

Read more
11 Nov 2015 08:56

Abcam Strikes Deal To Buy US-Based AxioMx For Up To USD45 Million

Read more
5 Nov 2015 16:31

Dividends Calendar - Week Ahead

Read more
5 Nov 2015 09:00

Abcam On Course To Meet Financial 2016 Expectations, Plans Investments

Read more
29 Oct 2015 16:13

AGM, EGM Calendar - Week Ahead

Read more
24 Sep 2015 16:20

DIRECTOR DEALINGS: ABCAM Company Secretary Smith Buys Shares

Read more
14 Sep 2015 07:21

LONDON BRIEFING: Chinese Industrial Production Disappoints

Read more
14 Sep 2015 06:37

ABCAM CFO To Step Down As It Says New Year Has Started Well

Read more
9 Sep 2015 06:54

Horizon Discovery Enters Licence, Supply Agreement With Abcam

Read more
8 Sep 2015 05:12

Earnings, Trading Statements Calendar - Week Ahead

Read more
7 Sep 2015 15:04

Earnings, Trading Statements Calendar - Week Ahead

Read more
23 Jul 2015 13:41

Abcam "back on track" with strong full-year revenues

(ShareCast News) - Antibodies and protein research products producer Abcam said it has been attracting and retaining consumers to its business and delivering market revenue growth. The group added the year ended 30 June 2015, was a successful one driven by its strategy, with revenues expected to ris

Read more
23 Jul 2015 09:29

WINNERS AND LOSERS SUMMARY: Unilever, Kingfisher Up As Aberdeen, SSE Drop

Read more
23 Jul 2015 07:09

Abcam Expects To Post 12% Revenue Growth For Full Year

Read more
2 Jul 2015 08:44

BROKER RATINGS SUMMARY: Berenberg Raises AstraZeneca To Buy from Hold

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.